HealthKey vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionHealthKeyIsomorphic Labs
Pricingcontactcontact
Best forClinical research sites needing faster enrollment without upfront software costs, CROs managing multi-site trials requiring rapid patient identificationPharma companies seeking AI drug discovery partnerships, Large-scale drug development programs
Standout featuresAI-powered patient prescreening · Daily EHR scans · Automated patient matching with evidenceBuilt on Nobel-winning AlphaFold system · Generative AI molecule design via Drug Design Engine · Predictive AI models for protein-ligand interactions
Viability score60/10072/100
APINoNo

HealthKey is the stronger pick for clinical research sites needing faster enrollment without upfront software costs; Isomorphic Labs fits better for pharma companies seeking ai drug discovery partnerships.

Built from live tool data, last verified 2026-08-23.

HealthKey
HealthKey

AI-powered patient identification for clinical trials that scans your EHR daily and emails eligible patients.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
3 views
7.4k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
Categories
🧬 Drug Discovery & Life Sciences🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
AI-powered patient prescreening
Daily EHR scans
Automated patient matching with evidence
Custom encoding of inclusion/exclusion criteria
HIPAA-compliant data processing
Integration with existing EHR systems
Patient ranking by likelihood to enroll
Multiple trial protocols support
Email alerts for eligible patients
Dashboard for qualified patients
Success-fee pricing (no upfront costs)
One-week onboarding
Scalable to millions of records
Free implementation and protocol setup (limited time)
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: HealthKey vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

HealthKey

30 mentions across 2 sources · 25% positive — critical

Hacker News, YouTube

What users praise

  • AI pre-screening scans entire EHR daily, eliminating weeks of manual chart review.
  • Success-fee pricing eliminates upfront costs, reducing financial risk for trial sites.
  • Free implementation and protocol setup through July 2026 lowers initial barrier.
  • Ranks patients by likelihood to enroll, focusing team effort on best prospects.

What frustrates them

  • No real user reviews or third-party testimonials exist, making trust hard to establish.
  • Success-fee model might discourage sites with low enrollment or high dropout rates.
  • Offering free services until 2026 raises questions about long-term pricing sustainability.
  • AI-driven prescreening may still require human oversight to validate matches.

Researched Aug 20, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Frequently Asked Questions

Which is better, HealthKey or Isomorphic Labs?

The best choice between HealthKey and Isomorphic Labs depends on your specific use case — we compare them independently on features, current pricing, integrations, and real-world signals (with an on-demand sentiment scan available for each). See the side-by-side breakdown above to match them to your needs.

What are the main differences between HealthKey and Isomorphic Labs?

The key differences include pricing model, feature set, platform support, and skill level requirements. Review the full comparison on RightAIChoice for a detailed breakdown.

Is there a free version of HealthKey or Isomorphic Labs?

Check the pricing section in the comparison for the latest pricing details on both tools, including free tiers, trial options, and paid plans.

More HealthKey or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026